Takeda
Manufacturing · Japan · 47,347 Employees
View Company Info for Free
About
Headquarters
1-1 Nihonbashi-honcho 2-chome, Chuo-ku, Tokyo, ...Phone Number
+81 332782111Website
www.takeda.comRevenue
$30.7 BillionStock Symbol
TAKIndustry
Most Recent Scoops
Open Position
Open Position
Who is Takeda
Founded in 1781, Takeda Pharmaceutical Company engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company is headquartered in Tokyo, JapanExplore more
Takeda Org Chart
Is Takeda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Takeda, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Takeda has recently received funding, and reach out quickly before it becomes old news!
Click to see if Takeda had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Takeda has new funding data
Earning: See what the market has to say on Takeda recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Takeda launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Takeda
Check out if Takeda is spiking on competitors!
Recommended Actions
Find VP level buyers at Takeda
Find 2 more new buyers
Compare Similar Companies to Takeda
Compare insights from companies similar to Takeda, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Takeda
$30.7B
47.3K
Compare CEO
How does Christophe Weber compare against Competing Companies' CEOs?
Christophe Weber
President & Chief Executive Officer at Takeda
Top 10%
CEO effectiveness to drive business results
Excellent
0%
Good
100%
Average
0%
Poor
0%
Very Bad
0%
Good
100%Bad
0%VS.
Brenton Saunders
CEO at Allergan Data Labs
Top 30%
CEO effectiveness to drive business results
Excellent
0%
Good
0%
Average
50%
Poor
50%
Very Bad
0%
Good
60%Bad
40%
Takeda Email Formats
Takeda uses at least 5 email formats with first.last (ex. John.Smith@takeda.com) being used 82.8% of the time
| Takeda Email Formats | Percentage | |
|---|---|---|
| first.last | John.Smith@takeda.com | 82.8% |
| first.last | John.Smith@shire.com | 2.2% |
| first initials + last | JSmith@shire.com | 1.5% |
| first + last | JohnSmith@takeda.com | |
| first_last | John_Smith@takeda.com | |
Get Verified Emails
View Email Formats for Takeda
Takeda Employee Growth Rate
View Takeda’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Takeda Tech Stack
A closer look at the technologies used by Takeda
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Takeda has more open roles in Legal than it has had at any time in the past 6 months. Technologies mentioned include: Remote.
Hiring Plans
Open Position
Open Position
Takeda News & Media
Takeda Pharmaceutical Company Limited (TAK) Q3 2025 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ETCompany ParticipantsChristopher O’Reilly - Head,...Takeda CEO Christophe Weber to step down following prolonged drop in company shares
Julie Kim, currently president of Takeda’s U.S. business unit, will succeed him, making her one of the few female chief executives in the pharma industry.Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over
Takeda CEO Christophe Weber will step down next June after more than 10 years leading the Japanese drugmaker.Takeda Announces Acquisition of Own Shares
OSAKA, Japan, January 30, 2025 – Takeda (TSE:4502/NYSE:TAK) announced that its Board of Directors resolved today to engage in the acquisition of its own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act of Japan, as detailed below.
Read more news
Frequently Asked Questions Regarding Takeda
Sign Up for FreeTo access detailed company insights
Founded in 1781, Takeda Pharmaceutical Company engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such... Read More
